Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2025-12-26 @ 3:49 AM
NCT ID:
NCT06655818
Group ID:
EG000
Title:
1.9 mg/kg Belantamab Mafodotin + 500mg Dostarlimab
Description:
Participants with Relapsed/Refractory Multiple Myeloma (RRMM) received 1.9 milligram (mg)/kilogram (kg) belantamab mafodotin intravenous (IV) infusion as powder for solution once every 3 weeks (Q3W) infused over 30- 60 minutes on day 1 of 21-day cycles in combination with 500 mg dostarlimab as a 30-minute IV infusion 1 hour after belantamab mafodotin end of infusion (EOI) on day 1 of 21-day cycles (Q3W).
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
4
Other Number Affected:
4
Other Number At Risk:
4
Study:
NCT06655818
Results Section:
NCT06655818
Adverse Events Module:
NCT06655818